HEADER MEMBRANE PROTEIN 26-JUN-20 6ZIS TITLE CRYSTAL STRUCTURE OF A CGRP RECEPTOR ECTODOMAIN HETERODIMER WITH BOUND TITLE 2 HIGH AFFINITY INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MALTOSE/MALTODEXTRIN-BINDING PERIPLASMIC PROTEIN,RECEPTOR COMPND 3 ACTIVITY-MODIFYING PROTEIN 1,CALCITONIN GENE-RELATED PEPTIDE TYPE 1 COMPND 4 RECEPTOR; COMPND 5 CHAIN: A; COMPND 6 SYNONYM: MMBP,MALTODEXTRIN-BINDING PROTEIN,MALTOSE-BINDING PROTEIN, COMPND 7 MBP,CALCITONIN-RECEPTOR-LIKE RECEPTOR ACTIVITY-MODIFYING PROTEIN 1, COMPND 8 CRLR ACTIVITY-MODIFYING PROTEIN 1,CGRP TYPE 1 RECEPTOR,CALCITONIN COMPND 9 RECEPTOR-LIKE RECEPTOR; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI (STRAIN K12), HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 83333, 9606; SOURCE 5 STRAIN: K12; SOURCE 6 GENE: MALE, B4034, JW3994, RAMP1, CALCRL, CGRPR; SOURCE 7 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HEK293 GNTI KEYWDS GPCR, CGRP, CLR, RAMP1, ECD, MEMBRANE PROTEIN, COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.M.SOUTHALL REVDAT 7 31-JAN-24 6ZIS 1 REMARK REVDAT 6 25-AUG-21 6ZIS 1 REMARK DBREF SEQADV ATOM REVDAT 5 18-AUG-21 6ZIS 1 COMPND SOURCE REMARK DBREF REVDAT 5 2 1 SEQADV LINK ATOM REVDAT 4 05-AUG-20 6ZIS 1 JRNL HETSYN REVDAT 3 29-JUL-20 6ZIS 1 COMPND REMARK HET HETNAM REVDAT 3 2 1 FORMUL LINK SITE ATOM REVDAT 2 22-JUL-20 6ZIS 1 JRNL REVDAT 1 15-JUL-20 6ZIS 0 JRNL AUTH S.J.BUCKNELL,M.A.ATOR,A.J.H.BROWN,J.BROWN,A.D.CANSFIELD, JRNL AUTH 2 J.E.CANSFIELD,J.A.CHRISTOPHER,M.CONGREVE,G.CSEKE, JRNL AUTH 3 F.DEFLORIAN,C.R.JONES,J.S.MASON,M.A.O'BRIEN,G.R.OTT, JRNL AUTH 4 M.PICKWORTH,S.M.SOUTHALL JRNL TITL STRUCTURE-BASED DRUG DISCOVERY JRNL TITL 2 OFN-((R)-3-(7-METHYL-1H-INDAZOL-5-YL)-1-OXO-1-(((S) JRNL TITL 3 -1-OXO-3-(PIPERIDIN-4-YL)-1-(4-(PYRIDIN-4-YL)PIPERAZIN-1-YL) JRNL TITL 4 PROPAN-2-YL)AMINO)PROPAN-2-YL)-2'-OXO-1', JRNL TITL 5 2'-DIHYDROSPIRO[PIPERIDINE-4,4'-PYRIDO[2,3-D][1, JRNL TITL 6 3]OXAZINE]-1-CARBOXAMIDE (HTL22562): A CALCITONIN JRNL TITL 7 GENE-RELATED PEPTIDE RECEPTOR ANTAGONIST FOR ACUTE TREATMENT JRNL TITL 8 OF MIGRAINE. JRNL REF J.MED.CHEM. V. 63 7906 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32558564 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01003 REMARK 2 REMARK 2 RESOLUTION. 1.73 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.73 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.62 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 56945 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.770 REMARK 3 FREE R VALUE TEST SET COUNT : 2718 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 4.6200 - 3.6600 1.00 2919 141 0.1601 0.2013 REMARK 3 2 3.6600 - 3.2000 1.00 2864 163 0.1856 0.2229 REMARK 3 3 3.2000 - 2.9100 1.00 2889 152 0.2003 0.2457 REMARK 3 4 2.9100 - 2.7000 1.00 2839 162 0.2043 0.2489 REMARK 3 5 2.7000 - 2.5400 1.00 2863 147 0.2020 0.2538 REMARK 3 6 2.5400 - 2.4100 1.00 2844 150 0.1997 0.2575 REMARK 3 7 2.4100 - 2.3100 1.00 2831 146 0.2054 0.2732 REMARK 3 8 2.3100 - 2.2200 1.00 2834 142 0.2047 0.2527 REMARK 3 9 2.2200 - 2.1400 1.00 2832 137 0.2068 0.2579 REMARK 3 10 2.1400 - 2.0800 1.00 2898 106 0.2110 0.2550 REMARK 3 11 2.0800 - 2.0200 1.00 2834 131 0.2162 0.2342 REMARK 3 12 2.0200 - 1.9600 1.00 2819 145 0.2317 0.3032 REMARK 3 13 1.9600 - 1.9200 1.00 2824 149 0.2545 0.3230 REMARK 3 14 1.9200 - 1.8700 1.00 2797 128 0.2809 0.2924 REMARK 3 15 1.8700 - 1.8300 1.00 2857 132 0.2934 0.4090 REMARK 3 16 1.8300 - 1.8000 1.00 2808 160 0.3037 0.3646 REMARK 3 17 1.8000 - 1.7600 1.00 2834 136 0.3204 0.4005 REMARK 3 18 1.7600 - 1.7300 1.00 2778 147 0.3228 0.3373 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.257 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.179 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.75 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4750 REMARK 3 ANGLE : 0.895 6448 REMARK 3 CHIRALITY : 0.051 686 REMARK 3 PLANARITY : 0.005 828 REMARK 3 DIHEDRAL : 20.131 1774 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 12.4819 -2.1958 -12.7957 REMARK 3 T TENSOR REMARK 3 T11: 0.1830 T22: 0.2150 REMARK 3 T33: 0.2060 T12: -0.0160 REMARK 3 T13: 0.0014 T23: -0.0164 REMARK 3 L TENSOR REMARK 3 L11: 0.1267 L22: 0.7426 REMARK 3 L33: 0.6316 L12: -0.2744 REMARK 3 L13: -0.3212 L23: 0.5313 REMARK 3 S TENSOR REMARK 3 S11: 0.0201 S12: 0.0424 S13: 0.0388 REMARK 3 S21: 0.0590 S22: -0.0694 S23: -0.0043 REMARK 3 S31: 0.0321 S32: -0.0684 S33: -0.0051 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ZIS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-JUN-20. REMARK 100 THE DEPOSITION ID IS D_1292109570. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 88 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96861 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57024 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.730 REMARK 200 RESOLUTION RANGE LOW (A) : 76.980 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.73 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4RWG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PH 5.5, 0.1 M AMMONIUM REMARK 280 ACETATE, 15 % PEG 10,000, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.57000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.13000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.49000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 49.13000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.57000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.49000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 0 REMARK 465 GLY A 1108 REMARK 465 ARG A 1109 REMARK 465 ALA A 1110 REMARK 465 VAL A 1111 REMARK 465 GLY A 2020 REMARK 465 SER A 2021 REMARK 465 ALA A 2022 REMARK 465 GLY A 2023 REMARK 465 SER A 2024 REMARK 465 ALA A 2025 REMARK 465 GLY A 2026 REMARK 465 SER A 2027 REMARK 465 ALA A 2028 REMARK 465 GLU A 2029 REMARK 465 ASP A 2030 REMARK 465 SER A 2031 REMARK 465 ALA A 2060 REMARK 465 GLU A 2061 REMARK 465 HIS A 2145 REMARK 465 HIS A 2146 REMARK 465 HIS A 2147 REMARK 465 HIS A 2148 REMARK 465 HIS A 2149 REMARK 465 HIS A 2150 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A2136 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN A 2118 O HOH A 2301 2.04 REMARK 500 O HOH A 2565 O HOH A 2575 2.11 REMARK 500 O HOH A 2306 O HOH A 2472 2.12 REMARK 500 O HOH A 2473 O HOH A 2479 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 57 30.21 -141.28 REMARK 500 LEU A 124 77.68 -151.84 REMARK 500 ALA A 170 -70.36 -80.10 REMARK 500 ASP A 211 -168.89 -119.83 REMARK 500 LYS A 258 77.79 -119.97 REMARK 500 TYR A 285 -52.11 -121.54 REMARK 500 ALA A1030 -126.16 -126.49 REMARK 500 GLN A2118 -0.58 72.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2581 DISTANCE = 6.23 ANGSTROMS REMARK 525 HOH A2582 DISTANCE = 7.11 ANGSTROMS DBREF 6ZIS A 2 368 UNP P0AEX9 MALE_ECOLI 26 392 DBREF 6ZIS A 1024 1111 UNP O60894 RAMP1_HUMAN 24 111 DBREF 6ZIS A 2029 2144 UNP Q16602 CALRL_HUMAN 29 144 SEQADV 6ZIS ALA A 0 UNP P0AEX9 EXPRESSION TAG SEQADV 6ZIS SER A 1 UNP P0AEX9 EXPRESSION TAG SEQADV 6ZIS ASN A 369 UNP P0AEX9 LINKER SEQADV 6ZIS ALA A 370 UNP P0AEX9 LINKER SEQADV 6ZIS ALA A 371 UNP P0AEX9 LINKER SEQADV 6ZIS ALA A 372 UNP P0AEX9 LINKER SEQADV 6ZIS GLU A 1022 UNP P0AEX9 LINKER SEQADV 6ZIS PHE A 1023 UNP P0AEX9 LINKER SEQADV 6ZIS GLY A 2020 UNP O60894 LINKER SEQADV 6ZIS SER A 2021 UNP O60894 LINKER SEQADV 6ZIS ALA A 2022 UNP O60894 LINKER SEQADV 6ZIS GLY A 2023 UNP O60894 LINKER SEQADV 6ZIS SER A 2024 UNP O60894 LINKER SEQADV 6ZIS ALA A 2025 UNP O60894 LINKER SEQADV 6ZIS GLY A 2026 UNP O60894 LINKER SEQADV 6ZIS SER A 2027 UNP O60894 LINKER SEQADV 6ZIS ALA A 2028 UNP O60894 LINKER SEQADV 6ZIS GLN A 2066 UNP Q16602 ASN 66 CONFLICT SEQADV 6ZIS GLN A 2118 UNP Q16602 ASN 118 CONFLICT SEQADV 6ZIS ASP A 2123 UNP Q16602 ASN 123 CONFLICT SEQADV 6ZIS HIS A 2145 UNP Q16602 EXPRESSION TAG SEQADV 6ZIS HIS A 2146 UNP Q16602 EXPRESSION TAG SEQADV 6ZIS HIS A 2147 UNP Q16602 EXPRESSION TAG SEQADV 6ZIS HIS A 2148 UNP Q16602 EXPRESSION TAG SEQADV 6ZIS HIS A 2149 UNP Q16602 EXPRESSION TAG SEQADV 6ZIS HIS A 2150 UNP Q16602 EXPRESSION TAG SEQRES 1 A 594 ALA SER ALA LYS ILE GLU GLU GLY LYS LEU VAL ILE TRP SEQRES 2 A 594 ILE ASN GLY ASP LYS GLY TYR ASN GLY LEU ALA GLU VAL SEQRES 3 A 594 GLY LYS LYS PHE GLU LYS ASP THR GLY ILE LYS VAL THR SEQRES 4 A 594 VAL GLU HIS PRO ASP LYS LEU GLU GLU LYS PHE PRO GLN SEQRES 5 A 594 VAL ALA ALA THR GLY ASP GLY PRO ASP ILE ILE PHE TRP SEQRES 6 A 594 ALA HIS ASP ARG PHE GLY GLY TYR ALA GLN SER GLY LEU SEQRES 7 A 594 LEU ALA GLU ILE THR PRO ASP LYS ALA PHE GLN ASP LYS SEQRES 8 A 594 LEU TYR PRO PHE THR TRP ASP ALA VAL ARG TYR ASN GLY SEQRES 9 A 594 LYS LEU ILE ALA TYR PRO ILE ALA VAL GLU ALA LEU SER SEQRES 10 A 594 LEU ILE TYR ASN LYS ASP LEU LEU PRO ASN PRO PRO LYS SEQRES 11 A 594 THR TRP GLU GLU ILE PRO ALA LEU ASP LYS GLU LEU LYS SEQRES 12 A 594 ALA LYS GLY LYS SER ALA LEU MET PHE ASN LEU GLN GLU SEQRES 13 A 594 PRO TYR PHE THR TRP PRO LEU ILE ALA ALA ASP GLY GLY SEQRES 14 A 594 TYR ALA PHE LYS TYR GLU ASN GLY LYS TYR ASP ILE LYS SEQRES 15 A 594 ASP VAL GLY VAL ASP ASN ALA GLY ALA LYS ALA GLY LEU SEQRES 16 A 594 THR PHE LEU VAL ASP LEU ILE LYS ASN LYS HIS MET ASN SEQRES 17 A 594 ALA ASP THR ASP TYR SER ILE ALA GLU ALA ALA PHE ASN SEQRES 18 A 594 LYS GLY GLU THR ALA MET THR ILE ASN GLY PRO TRP ALA SEQRES 19 A 594 TRP SER ASN ILE ASP THR SER LYS VAL ASN TYR GLY VAL SEQRES 20 A 594 THR VAL LEU PRO THR PHE LYS GLY GLN PRO SER LYS PRO SEQRES 21 A 594 PHE VAL GLY VAL LEU SER ALA GLY ILE ASN ALA ALA SER SEQRES 22 A 594 PRO ASN LYS GLU LEU ALA LYS GLU PHE LEU GLU ASN TYR SEQRES 23 A 594 LEU LEU THR ASP GLU GLY LEU GLU ALA VAL ASN LYS ASP SEQRES 24 A 594 LYS PRO LEU GLY ALA VAL ALA LEU LYS SER TYR GLU GLU SEQRES 25 A 594 GLU LEU ALA LYS ASP PRO ARG ILE ALA ALA THR MET GLU SEQRES 26 A 594 ASN ALA GLN LYS GLY GLU ILE MET PRO ASN ILE PRO GLN SEQRES 27 A 594 MET SER ALA PHE TRP TYR ALA VAL ARG THR ALA VAL ILE SEQRES 28 A 594 ASN ALA ALA SER GLY ARG GLN THR VAL ASP GLU ALA LEU SEQRES 29 A 594 LYS ASP ALA GLN THR ASN ALA ALA ALA GLU PHE THR THR SEQRES 30 A 594 ALA CYS GLN GLU ALA ASN TYR GLY ALA LEU LEU ARG GLU SEQRES 31 A 594 LEU CYS LEU THR GLN PHE GLN VAL ASP MET GLU ALA VAL SEQRES 32 A 594 GLY GLU THR LEU TRP CYS ASP TRP GLY ARG THR ILE ARG SEQRES 33 A 594 SER TYR ARG GLU LEU ALA ASP CYS THR TRP HIS MET ALA SEQRES 34 A 594 GLU LYS LEU GLY CYS PHE TRP PRO ASN ALA GLU VAL ASP SEQRES 35 A 594 ARG PHE PHE LEU ALA VAL HIS GLY ARG TYR PHE ARG SER SEQRES 36 A 594 CYS PRO ILE SER GLY ARG ALA VAL GLY SER ALA GLY SER SEQRES 37 A 594 ALA GLY SER ALA GLU ASP SER ILE GLN LEU GLY VAL THR SEQRES 38 A 594 ARG ASN LYS ILE MET THR ALA GLN TYR GLU CYS TYR GLN SEQRES 39 A 594 LYS ILE MET GLN ASP PRO ILE GLN GLN ALA GLU GLY VAL SEQRES 40 A 594 TYR CYS GLN ARG THR TRP ASP GLY TRP LEU CYS TRP ASN SEQRES 41 A 594 ASP VAL ALA ALA GLY THR GLU SER MET GLN LEU CYS PRO SEQRES 42 A 594 ASP TYR PHE GLN ASP PHE ASP PRO SER GLU LYS VAL THR SEQRES 43 A 594 LYS ILE CYS ASP GLN ASP GLY ASN TRP PHE ARG HIS PRO SEQRES 44 A 594 ALA SER GLN ARG THR TRP THR ASP TYR THR GLN CYS ASN SEQRES 45 A 594 VAL ASN THR HIS GLU LYS VAL LYS THR ALA LEU ASN LEU SEQRES 46 A 594 PHE TYR LEU HIS HIS HIS HIS HIS HIS HET GLC B 1 12 HET GLC B 2 11 HET PG4 A2201 13 HET PG4 A2202 13 HET PG4 A2203 13 HET 3N6 A2204 54 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM 3N6 N-{(1S)-5-AMINO-1-[(4-PYRIDIN-4-YLPIPERAZIN-1-YL) HETNAM 2 3N6 CARBONYL]PENTYL}-3,5-DIBROMO-NALPHA-{[4-(2-OXO-1,4- HETNAM 3 3N6 DIHYDROQUINAZOLIN-3 (2H)-YL)PIPERIDIN-1-YL]CARBONYL}- HETNAM 4 3N6 D-TYROSINAMIDE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN 3N6 OLCEGEPANT FORMUL 2 GLC 2(C6 H12 O6) FORMUL 3 PG4 3(C8 H18 O5) FORMUL 6 3N6 C38 H47 BR2 N9 O5 FORMUL 7 HOH *282(H2 O) HELIX 1 AA1 GLY A 18 GLY A 34 1 17 HELIX 2 AA2 LYS A 44 THR A 55 1 12 HELIX 3 AA3 ARG A 68 SER A 75 1 8 HELIX 4 AA4 ASP A 84 ASP A 89 1 6 HELIX 5 AA5 TYR A 92 VAL A 99 1 8 HELIX 6 AA6 THR A 130 GLU A 132 5 3 HELIX 7 AA7 GLU A 133 ALA A 143 1 11 HELIX 8 AA8 GLU A 155 ASP A 166 1 12 HELIX 9 AA9 ASN A 187 ASN A 203 1 17 HELIX 10 AB1 ASP A 211 LYS A 221 1 11 HELIX 11 AB2 GLY A 230 TRP A 232 5 3 HELIX 12 AB3 ALA A 233 LYS A 241 1 9 HELIX 13 AB4 ASN A 274 TYR A 285 1 12 HELIX 14 AB5 THR A 288 LYS A 299 1 12 HELIX 15 AB6 LEU A 306 ALA A 314 1 9 HELIX 16 AB7 ASP A 316 GLY A 329 1 14 HELIX 17 AB8 GLN A 337 SER A 354 1 18 HELIX 18 AB9 THR A 358 ALA A 1026 1 20 HELIX 19 AC1 ASN A 1031 CYS A 1040 1 10 HELIX 20 AC2 CYS A 1040 GLY A 1052 1 13 HELIX 21 AC3 GLU A 1053 TRP A 1056 5 4 HELIX 22 AC4 ASP A 1058 LEU A 1080 1 23 HELIX 23 AC5 ASN A 1086 PHE A 1101 1 16 HELIX 24 AC6 GLN A 2033 ASP A 2055 1 23 HELIX 25 AC7 TYR A 2124 ASN A 2128 5 5 HELIX 26 AC8 GLU A 2133 TYR A 2143 1 11 SHEET 1 AA1 6 VAL A 37 GLU A 40 0 SHEET 2 AA1 6 LEU A 9 TRP A 12 1 N ILE A 11 O GLU A 40 SHEET 3 AA1 6 ILE A 61 ALA A 65 1 O PHE A 63 N TRP A 12 SHEET 4 AA1 6 PHE A 260 ILE A 268 -1 O GLY A 267 N ILE A 62 SHEET 5 AA1 6 TYR A 108 GLU A 113 -1 N GLU A 113 O GLY A 262 SHEET 6 AA1 6 ALA A 303 VAL A 304 -1 O ALA A 303 N VAL A 112 SHEET 1 AA2 5 VAL A 37 GLU A 40 0 SHEET 2 AA2 5 LEU A 9 TRP A 12 1 N ILE A 11 O GLU A 40 SHEET 3 AA2 5 ILE A 61 ALA A 65 1 O PHE A 63 N TRP A 12 SHEET 4 AA2 5 PHE A 260 ILE A 268 -1 O GLY A 267 N ILE A 62 SHEET 5 AA2 5 GLU A 330 ILE A 331 1 O GLU A 330 N VAL A 261 SHEET 1 AA3 2 ARG A 100 TYR A 101 0 SHEET 2 AA3 2 LYS A 104 LEU A 105 -1 O LYS A 104 N TYR A 101 SHEET 1 AA4 4 SER A 147 LEU A 149 0 SHEET 2 AA4 4 THR A 224 ASN A 229 1 O ALA A 225 N SER A 147 SHEET 3 AA4 4 SER A 116 ASN A 120 -1 N ASN A 120 O ALA A 225 SHEET 4 AA4 4 TYR A 244 THR A 247 -1 O GLY A 245 N TYR A 119 SHEET 1 AA5 2 TYR A 169 LYS A 172 0 SHEET 2 AA5 2 ASP A 179 GLY A 184 -1 O ASP A 179 N LYS A 172 SHEET 1 AA6 2 THR A 251 PHE A 252 0 SHEET 2 AA6 2 GLN A 255 PRO A 256 -1 O GLN A 255 N PHE A 252 SHEET 1 AA7 2 TYR A2064 CYS A2065 0 SHEET 2 AA7 2 VAL A2078 ALA A2079 -1 O VAL A2078 N CYS A2065 SHEET 1 AA8 2 THR A2068 TRP A2069 0 SHEET 2 AA8 2 CYS A2074 TRP A2075 -1 O TRP A2075 N THR A2068 SHEET 1 AA9 2 THR A2082 LEU A2087 0 SHEET 2 AA9 2 LYS A2100 CYS A2105 -1 O VAL A2101 N GLN A2086 SSBOND 1 CYS A 1027 CYS A 1082 1555 1555 2.03 SSBOND 2 CYS A 1040 CYS A 1072 1555 1555 2.05 SSBOND 3 CYS A 1057 CYS A 1104 1555 1555 2.04 SSBOND 4 CYS A 2048 CYS A 2074 1555 1555 2.03 SSBOND 5 CYS A 2065 CYS A 2105 1555 1555 2.02 SSBOND 6 CYS A 2088 CYS A 2127 1555 1555 2.04 LINK O4 GLC B 1 C1 GLC B 2 1555 1555 1.40 CISPEP 1 TRP A 1084 PRO A 1085 0 -4.80 CRYST1 71.140 76.980 98.260 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014057 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012990 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010177 0.00000